The overlooked tool: kidney biopsy in progressive renal decline of type 2 diabetes patients

Affiliations

Editorial

Sang Youb Han. Kidney Res Clin Pract. 2025 Jan.

. 2025 Jan;44(1):4-5.

doi: 10.23876/j.krcp.24.999. Epub 2024 Dec 11.

¹ Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.

No abstract available

Conflict of interest statement

Conflicts of interest

The author has no conflicts of interest to declare.

Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus.
Kim WJ, Oh T, Heo NH, Kwon K, Shin GE, Jeong SH, Lee JH, Park S, Cho NJ, Gil HW, Lee EY. Kim WJ, et al. Kidney Res Clin Pract. 2025 Jan;44(1):91-101. doi: 10.23876/j.krcp.23.059. Epub 2024 Jan 12. Kidney Res Clin Pract. 2025. PMID: 38212871 Free PMC article.

1. Jiang G, Luk AOY, Tam CHT, et al. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with type 2 diabetes. Kidney Int. 2019;95:178–187. doi: 10.1016/j.kint.2018.08.026. - DOI - PubMed
1. Kim WJ, Oh T, Heo NH, et al. Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus. Kidney Res Clin Pract. 2024 Jan 12; doi: 10.23876/j.krcp.23.059. [Epub]. DOI: 10.23876/j.krcp.23.059. - DOI - DOI - PMC - PubMed
1. Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis. 2002;39:713–720. doi: 10.1053/ajkd.2002.31988. - DOI - PubMed
1. Ma MKM, Yap DYH, Li CL, et al. Low-dose corticosteroid and mycophenolate for primary treatment of minimal change disease. QJM. 2020;113:399–403. doi: 10.1093/qjmed/hcz297. - DOI - PubMed
1. Mccafferty K, Caplin B, Knight S, et al. HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol. BMJ Open. 2020;10:e033923. doi: 10.1136/bmjopen-2019-033923. - DOI - PMC - PubMed